Back to Research Hub
Schrödinger, Inc.
SDGR
$14.52+0.12 (+0.83%)
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery.
StreetsValue research for Schrödinger, Inc. (SDGR)
Members get the full report for Schrödinger, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.